代表性论文（近五年第一及通讯作者论文）:

[1] Ou, L., X. Wang, S. Cheng, M. Zhang, R. Cui, C. Hu, S. Liu, Q. Tang, Y. Peng, R. Chai, S. Xie, Shaoxiang Wang*, W. Huang*, and X. Wang*, Verdinexor, a Selective Inhibitor of Nuclear Exportin 1, Inhibits the Proliferation and Migration of Esophageal Cancer via XPO1/c-Myc/FOSL1 Axis. Int J Biol Sci, 2022. 18(1): p. 276-291. (IF:10.075, Corresponding author)

[2] Qian Tang^#, Yue Wang^#, Ling Ou, Jieling Li, Kai Zheng, Hui Zhan, Jiayu Gu, Guibao Zhou, Shouxia Xie, Jianping Zhang, Wei Huang*, Shaoxiang Wang* and Xiao Wang*, Downregulation of ACE2 expression by SARS-CoV-2 worsens the prognosis of KIRC and KIRP patients via metabolism and immunoregulation. Int J Biol Sci. 2021; 17(8): 1925–1939. (IF:10.075, Corresponding author)

[3] Nan Li^#, Kaisheng Liu^#, Shaowei Dong, Ling Ou, Jieling Li, Minshan Lai, Yue Wang, Yucheng Bao, Huijie Shi, Xiao Wang*, Shaoxiang Wang*, Identification of CHRNB4 as a Diagnostic/Prognostic Indicator and Therapeutic Target in Human Esophageal Squamous Cell Carcinoma, Front Oncol, 2020 Nov 16;10:571167. (IF: 6.244, Corresponding author)

[4] Liu, S., Y. Cheng, Shaoxiang Wang*, and H. Liu, Circadian Clock Genes Modulate Immune, Cell Cycle and Apoptosis in the Diagnosis and Prognosis of Pan-Renal Cell Carcinoma. Front Mol Biosci, 2021. 8: p. 747629. (IF:6.113, Corresponding author)

[5] Jieling Li^#, Liyuan Zhou^#, Ying Liu, Lingzhi Yang, Dayi Jiang, Kuan Li, Shouxia Xie, Xiao Wang*, Shaoxiang Wang*, Comprehensive Analysis of Cyclin Family Gene Expression in Colon Cancer. Front Oncol, 2021 Apr 29;11:674394. (IF:6.244, Corresponding author)

[6] BinYuan Hu^#, ShaoXiang Wang#, YongMing Yan, JiaWang Liu, DaPeng Qina, YongXian Cheng*, Spiromyrrhenes A–D: unprecedented diterpene–sesquiterpene heterodimers as intermolecular [4 + 2] cycloaddition products from Resina Commiphora that inhibit tumor stemness in esophageal cancer. Organic Chemistry Frontiers, 2020,7, 2710-2718. (IF:5.281, Co-first author)

[7] Liang, Y. ^#, Shaoxiang Wang^#, X. Huang, R. Chai, Q. Tang, R. Yang, X. Huang, X. Wang, and K. Zheng, Dysregulation of Circadian Clock Genes as Significant Clinic Factor in the Tumorigenesis of Hepatocellular Carcinoma. Comput Math Methods Med, 2021. 2021: p. 8238833. (IF:2.238, Co-first author)

[8] Guifeng Xu^#, Ling Ou^#, Ying Liu^#, Xiao Wang, Kaisheng Liu, Jieling Li, Junjun Li, Shaoqi Wang, Dane Huang, Kai Zheng*, Shaoxiang Wang*, Upregulated expression of MMP family genes is associated with poor survival in patients with esophageal squamous cell carcinoma via regulation of proliferation and epithelial‑mesenchymal transition, Oncology Reports, 2020, 44(1): 29-42. (IF: 3.906, Corresponding author)

[9] Jieling Li^#, Xiao Wang^#, Kai Zheng, Ying Liu, Junjun. Li, Shaoqi Wang, Kaisheng Liu, Xun Song, Nan Li, Shouxia Xie*, Shaoxiang Wang*, The clinical significance of collagen family gene expression for esophageal squamous cell carcinoma, PeerJ, 2019 Oct 4;7:e7705.（IF：2.984, Corresponding author）

[10] Wing-Fu Lai^#, Chengshen Hu^#, Guoxing Deng, Kwok-Ho Lui, Xiao Wang, Tik-Hung Tsoi, Shaoxiang Wang*, Wing-Tak Wong*, A Biocompatible and Easy-to-make Polyelectrolyte Dressing with Tunable Drug Delivery Properties for Wound Care, International Journal of Pharmaceutics, 2019, 16(566): 101-110. (IF:5.875, Corresponding author)

[11] Jixian Xiong^#, Shaoxiang Wang#, Tie Chen, Xingsheng Shu, Xianming Mo, Gang Chang, Jiajie Chen, Chenyuang Li, Hui Luo, Jiing Dwan Lee*, Verteporfin blocks Clusterin which is required for survival of gastric cancer stem cell by modulating HSP90 function, International Journal of Biological Sciences, 2019, 15(2): 312-324. (IF: 6.580, Co-first author)

[12] Shaoxiang Wang#, Kaisheng Liu, Yifei Lou, Shaoqi Wang, Yongbo Peng, Jianping Chen, Jiahao Huang,  Shouxia Xie*, Liang Cui*,  Xiao Wang*, RNase H meets molecular beacons: an ultrasensitive fluorometric assay for nucleic acids, Microchimica Acta, 2018, 185:375. (IF: 5.833, First author)

[13] Jiwei Ma^#, Xiao Wang^#, Lei Chang, Xueyun Zhong, Haiyan Jing, Xiaolong Zhu, Shaoxiang Wang*, Weiwei Xiao*, CD44 collaborates with ERBB2 mediate radiation resistance via p38 phosphorylation and DNA homologous recombination pathway in prostate cancer, Experimental Cell Research, 2018, 370(1): 58-67. (IF: 3.905, Co-corresponding author)

[14] Yong Zhang^#, Yulin Wen, Jiwei Ma, Jiecheng Ye, Xiao Wang, Jianxian Huang, Chaoyue Meng, Xiaoze Xu, Shaoxiang Wang*, Xueyun Zhong*, Tetrandrine inhibits glioma stem-like cells by repressing beta-catenin expression. International journal of oncology, 2017, 50: 101-110. (IF: 3.0789, Co-corresponding author)

[15] Shaoqi Wang^#, Xiao Wang^#, Kai Zheng, Kaisheng Liu, Shaoxiang Wang*, Conghua Xie*, Simultaneous targeting PI3K and PERK pathways promotes cell death and improves the clinical prognosis in esophageal squamous carcinoma, Biochemical and Biophysical Research Communications, 2017, 493(1): 534-541. (IF: 2.4660, Co-corresponding author)

[16] Ru Li^#, Haiying Li^#, Shaoxiang Wang#, Jiwei Ma, Yong Zhang, Jiecheng Ye, Yulin Wen, Xiao Wang, Xueyun Zhong*, Weiwei Xiao*. Novel prognostic value of nuclear lactate dehydrogenase-A in esophageal squamous cell carcinoma,  International Journal of Clinical and Experimental Pathology, 2016, 9(3): 3708-3716.  (IF: 1.7059, Co-first author)

[17] Shaoxiang Wang#, Zhan Du^#, Jie Luo, Xiao Wang, Haiying Li, Yuting Liu, Yong Zhang, Jiwei Ma, Weiwei Xiao, Yifei Wang^*, Xueyun Zhong^*, Inhibition of heat shock protein 90 suppresses squamous carcinogenic progression in a mouse model of esophageal cancer, Journal of Cancer Research and Clinical Oncology, 2015, 141 (8): 1405-16. (IF: 3.5024, First author)